Navigation Links
PharmacoFore, Inc. Secures $10 Million in Equity Financing From Founders Fund
Date:12/27/2011

SAN CARLOS, Calif., Dec. 27, 2011 /PRNewswire/ -- PharmacoFore, Inc., a privately held biopharmaceutical company, today announced a $10 million round of equity financing from Founders Fund and the addition of Founders Fund partner Ken Howery to its Board of Directors.  

PharmacoFore uses innovative synthetic organic chemistry to create novel medicines for treating a variety of conditions related to the central and peripheral nervous systems.  One of its key platform technologies has generated a series of novel molecules that it believes will facilitate prevention of the abuse and misuse of prescription drugs -- now the leading cause of accidental death in the United States, surpassing auto-related fatalities. 

Wes Sterman, CEO of PharmacoFore, Inc., commented, "We are thrilled to have the enthusiastic support of Founders Fund as we advance our pipeline, along with partners, to regulatory approval and commercialization throughout the world." 

Ken Howery is a co-founder of PayPal and served as the company's first CFO prior to its initial public offering and subsequent sale to eBay.  Before launching Founders Fund, Ken Howery was a member of the research and trading teams at Clarium Capital Management.

Founders Fund investment philosophy is distinguished by its focus on innovative, cost-effective companies that can capture multi-billion dollar markets through transformational technologies that can lead to positive change in the world.

About Founders Fund
Founders Fund provides capital to transformational businesses run by world-class entrepreneurs. Companies the firm has backed include Facebook (managing partner Peter Thiel was Facebook's first outside backer), Quantcast, SpaceX, Palantir Technologies, RoboteX, Spotify, Yammer, Mint.com, and Slide. The firm, which pursues a founder-friendly investment strategy, is overseen by four managing partners, all of whom have founded companies worth more than $1 billion: Peter Thiel (PayPal); Ken Howery (PayPal); Luke Nosek (PayPal); and Sean Parker (Napster; Plaxo, Causes; founding president, Facebook).

About PharmacoFore, Inc.
PharmacoFore, Inc., is a privately held biopharmaceutical company focused on creating novel medicines that provide clear clinical benefits over existing drugs, enhance patient care, and prevent the misuse, abuse, and overdose of prescription medications.  

PharmacoFore, Inc. Contact:
A. Gregory Sturmer
VP, Finance and Chief Financial Officer
650-331-4010
gsturmer@pfore.com

Media Contact:
Tiberend Strategic Advisors, Inc.
212-827-0020
Jason Rando / Andrew Mielach
jrando@tiberend.com / amielach@tiberend.com

 


'/>"/>
SOURCE PharmacoFore, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
2. AuraSense Therapeutics Secures Series B Equity Investment
3. United Spinal Secures Leading Public Policy and Durable Medical Equipment Specialist: Alex Bennewith is New Director of Government Relations
4. ACT Secures First Patent for Generating Hemangioblast Cells to Treat a Broad Spectrum of Vascular and Hematopoietic Disorders
5. Awarepoint Corporation Secures $27 Million in New Financing: Kleiner Perkins Caufield & Byers Leads Round
6. NeurogesX, Inc. Secures $20 Million Debt Facility
7. Bacterin Secures $15 Million Credit Facility with MidCap Financial and Silicon Valley Bank
8. SurgiQuest, Inc. Secures $19 Million to Fund Commercialization and Launch the Next Generation Access Technology Cited by Surgeons as The Future of Minimally Invasive Surgery
9. Digital Assent Secures $7.5 Million Series B Funding
10. Precyse Secures Healthcare IT Executive Chris Powell as New President
11. Ethicon, Inc. Announces Availability of ETHICON SECURESTRAP™ 5mm Absorbable Strap Fixation Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... company focused on the development of oral drug delivery systems, ... Securities Authority to dual-list its common stock on the Tel ... on the TASE on July 12, 2017 under the ticker ... it is expected that Oramed will be included in the ...
(Date:7/5/2017)... , July 5, 2017   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade cell ... freeze media ("BioLife"), today announced that it has ... debt holder and largest shareholder, to modify its existing ... Pursuant to the modification, WAVI agreed to exchange its ...
(Date:6/30/2017)... ROCKVILLE, Md. , June 30, 2017 ... that since the start of May, at least ten ... financings include private investments, public offerings and a loan ... $3.3 million to almost $80 million.  Kalorama Information provides ... customers of its Diagnostics Knowledge Center. ...
Breaking Medicine Technology:
(Date:7/21/2017)... CA (PRWEB) , ... July 21, 2017 , ... West ... “Tu” Tuantu Doan Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West ... 27 years of experience in dermatology, skin cancer , and more. She graduated ...
(Date:7/20/2017)... ... July 20, 2017 , ... TransPixel Volume 2 is a set of transitions ... timeline. This effect isolates horizontal and vertical lines of pixels and sorts their pixels ... or flipping animation and can be changed using a drop-down menu. Create amazing and ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... firm headquartered in Houston, is pleased to announce their expansion to the Midwest ... housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John Peck ...
(Date:7/20/2017)... ... July 20, 2017 , ... Doctors on Liens, the leading network of medical ... , directed by Dr. Russell Horine, DC to their exclusive list of medical professionals. ... Russell Horine serving as the clinic director and his son Dr. Lee Horine and ...
(Date:7/20/2017)... ... July 20, 2017 , ... The Dermatology Clinic announced ... Dunbar received his BS in Biology from LSU, graduating summa cum laude. He attended ... President. After his residency in St. Louis, Dr. Dunbar moved to New York to ...
Breaking Medicine News(10 mins):